Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03831412 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Therapy for Insomnia vs. Exposure, Relaxation, and Rescripting Therapy

A NA study of Insomnia and Trauma, sponsored by University of Tul.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT03831412: Completed NA study of Insomnia and Trauma, sponsored by University of Tul.

NCT03831412 is a NA study of Insomnia and Trauma that has completed, run by University of Tul. The registered enrollment target is 13 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03831412, a NA study of Insomnia and Trauma, has completed, sponsored by University of Tul.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The objective of this project is to determine if directly addressing disturbed sleep and nightmares will impact client reports of suicidal ideation.

Primary Outcome

Change in frequency of insomnia symptoms

Interventions

  • BEHAVIORAL CBT-I
  • BEHAVIORAL ERRT

Study Locations (1)

Oklahoma

  • Lorton Hall - Tulsa

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2017-08-01
Est. Completion 2021-01-31
Phase NA
University of Tul

5 total trials

What the finished NCT03831412 record still lists

NCT03831412 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (92% lower).

The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which CBT-I is the first listed.

NCT03831412 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03831412 about?

NCT03831412 is a clinical study titled "Cognitive Behavioral Therapy for Insomnia vs. Exposure, Relaxation, and Rescripting Therapy". The objective of this project is to determine if directly addressing disturbed sleep and nightmares will impact client reports of suicidal ideation.

What is the current status of trial NCT03831412?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-08-01. Estimated completion is 2021-01-31.

What conditions does trial NCT03831412 study?

This clinical trial studies the following conditions: Insomnia, Trauma, Nightmare.

What interventions are being tested in trial NCT03831412?

The interventions under investigation include: CBT-I (BEHAVIORAL), ERRT (BEHAVIORAL).

Who is sponsoring clinical trial NCT03831412?

This trial is sponsored by University of Tul, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03831412 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03831412's enrollment target sits among peer trials

13 144th of 151 higher than 7 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03831412, the US trial registry maintained by the National Library of Medicine. NCT03831412 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.